orforglipron semaglutide HUGE news in the GLP-1 space! has outperformed oral in the ACHIEVE-3 clinical trial in patients with type 2 diabetes. Comment your thoughts below! ⬇️ Orforglipron vs Oral Semaglutide: Update

In recent years, there has been a proliferation of newer therapeutic agents, revolutionizing the treatment landscape for obesity

Last month, the TGA issued a statement announcing limited supplies of the drug had commenced distribution to select community pharmacies, with prescribers requested to prioritise people using the drug to manage diabetes

Works Cited:

See if you are eligible at Noom.com Noom Microdose GLP-1 Costs One of the biggest hurdles for GLP-1 treatments is the price tag, as many insurance plans do not cover weight loss medications

Inflammation is often exacerbated by an increase in visceral adiposity and the pro-inflammatory impact of hyperandrogenism [65]

Sometimes the biggest insight comes from recognizing that what looked like one nutrient is actually a family of molecules with different biological functions